Hoteit, Lara
Deeb, Andrew-Paul
Andraska, Elizabeth A.
Kaltenmeier, Christof
Yazdani, Hamza O.
Tohme, Samer
Neal, Matthew D.
Mota, Roberto I.
Article History
Accepted: 10 November 2021
First Online: 8 December 2021
Declarations
:
: MDN has the following financial relationships to disclose: Consultant, External Scientific Advisor for Anticoagulation Science for Janssen Pharmaceuticals (Johnson & Johnson), research funding from Haemonetics and Instrument Laboratories, Scientific Advisory Board of Haima Therapeutics, Trauma Advisory Board, CSL Behring, and US Patent 9,072,760 <i>TLR4 inhibitors for the treatment of human infectious and inflammatory disorders</i> (issued to Neal, Wipf, Hackam, Sodhi).The additional authors declare that no significant conflicts of interest exist.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.